Myriad Genetics EVP reports 93,493-share stake

MYRIAD GENETICS INC (MYGN) reported an initial statement of beneficial ownership for Vishal Sikri, who serves as EVP, Commercial.

Rhea-AI Filing Summary

MYRIAD GENETICS INC (MYGN) reported an initial statement of beneficial ownership for Vishal Sikri, who serves as EVP, Commercial. The filing lists 93,493 shares of Common Stock held with direct ownership after the reported event, and does not report any concurrent purchases, sales, or derivative positions.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sikri Vishal

Role EVP, Commercial

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 93,493 shares (Direct)

Key Figures

Common Stock beneficially owned: 93,493 shares Ownership type: Direct Reporting person role: EVP, Commercial

3 metrics

Common Stock beneficially owned 93,493 shares Shares of Myriad Genetics common stock beneficially owned following the reported event

Ownership type Direct Ownership of the reported 93,493 Myriad Genetics common shares is classified as direct

Reporting person role EVP, Commercial Officer title of reporting person Vishal Sikri at Myriad Genetics Inc

Key Terms

beneficial ownership, Form 3, Common Stock, Power of Attorney

4 terms

beneficial ownership financial

"reported an initial statement of beneficial ownership for Vishal Sikri"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 3 regulatory

"The Form 3 records his initial beneficial ownership position"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Common Stock financial

"93,493 shares of Common Stock held with direct ownership"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the reporting insider in MYGN’s latest Form 3 filing?

The reporting insider is Vishal Sikri, who is identified as EVP, Commercial at Myriad Genetics Inc. The Form 3 records his initial beneficial ownership position in the company’s common stock.

How many MYGN shares does Vishal Sikri beneficially own according to this Form 3?

According to the Form 3, Vishal Sikri beneficially owns 93,493 shares of Myriad Genetics common stock following the reported event, held as direct ownership.

Does this MYGN Form 3 report any insider buying or selling activity?

No. The Form 3 lists a holding entry only and shows no reported purchases or sales of Myriad Genetics common stock. It is an initial beneficial ownership report, not a transaction Form 4 or Form 5.

What type of security is reported in Vishal Sikri’s MYGN Form 3?

The filing reports ownership of Common Stock of Myriad Genetics Inc. No options, warrants, or other derivative securities are listed in the derivative holdings section of this Form 3.

Is any Rule 10b5-1 trading plan disclosed in this MYGN Form 3?

No. The data indicate no Rule 10b5-1 trading plan is reported in connection with this Form 3. The filing serves only to disclose Mr. Sikri’s existing beneficial ownership of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:31 PM Accepted by SEC EDGAR 09/17/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sikri Vishal

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/16/2026

3. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Commercial

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	93,493	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	By: Justin Hunter For: Vishal Sikri	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)